|
|
|
|
 |
Message from the Director
As we are all aware of, molecular medicine
is one of the core research fields in biomedical sicence which will
be leading the 21st century. With the completion of human genome
project the structures and functions of human genes are to be identified.
This will definately lead to an era of molecular medicine whereby
the role of genes and their abnormal functions can be identified
for each disease |
and
most of diseases can be cured applying molecular therapy. With the
development of new methods of diagnosing and treating various kinds
of diseases at molecular level it seems that the greatest hope of
human beings, conquering disases which could not be cured by exsisting
medical treatments, can be realized in the 21st century.
In order to challenge this era of molecular medicine our center
has accumulated research and development capabilities by carrying
out research projects on the functions and identification of disease
related genes and has successfully performed basic research works
on the development of our unique molecular therapeutic vectors.
As a result of such effort we were able to publish research papers
in the prestigeous international journals and apply for domestic
and overseas patent for the molecular therapeutic vectors we have
developed.
Based on these research outcomes we have created our own core research
team by carefully selecting basic and clinical researchers based
on their research outputs and competencies in order to further develop
our unique internationally competitive molecular therapy method
in the coming years. We are trying to secure core research facilities
aiming at becoming an internationally competitive molecular therapy
research center. With this strategy we are sure that our center
can reach world-class by concentrating on the development of gene
elements and design and production of therapeutic vectors which
can be used for molecular genetic mechanism and gene therapy of
diseases.
We are striving to become one of the best world-class research centers
in the field of molecular theray in this coming era of molecular
medicine thereby contributing to the advancement of basic science
and enhancement of the level of medical research in Korea and finally
for the improvement of human health. Lastly, I would like to express
my sincere thanks to the Minstry of Sicence and Technology, Korea
Sicence Foundation and Sungkyunkwan University for their utmost
support in the establishment and development of our Molecular Therapy
Research Center.
Je-Ho Lee, M.D., Ph.D.
Director of MTRC |
|
Introduction